Kymera Therapeutics
biopharmaceutical company
Press Enter · cited answer in seconds
0 sources
Financials
Self-reported XBRL data from 7 annual filings
Revenue
$39.21M
Net Income
-$311.35M
Assets
$1.74B
EPS (diluted)
$-3.69
■ Revenue ■ Net Income
Source: SEC EDGAR · latest 10-K filed 2025-12-31 · accession
0001193125-26-073395Kymera Therapeutics
Summary
Kymera Therapeutics is a public company[1].
Key Facts
- Kymera Therapeutics's instance of is recorded as public company[2].
- Kymera Therapeutics's headquarters location is recorded as Watertown[3].
- Kymera Therapeutics's stock exchange is recorded as Nasdaq[4].
- Kymera Therapeutics's industry is recorded as pharmaceutical industry[5].
- Kymera Therapeutics's official website is recorded as https://www.kymeratx.com/[6].
- Kymera Therapeutics's ISIN is recorded as US5015751044[7].
- Kymera Therapeutics's Crunchbase organization ID is recorded as kymera-therapeutics[8].
- Kymera Therapeutics's Central Index Key is recorded as 0001815442[9].
Body
Operations
Kymera Therapeutics's headquarters location is recorded as Watertown[3].
Industry
Kymera Therapeutics's industry is recorded as pharmaceutical industry[5].
Ownership
Kymera Therapeutics's stock exchange is recorded as Nasdaq[4].